PUBLISHER: Grand View Research | PRODUCT CODE: 2188738
PUBLISHER: Grand View Research | PRODUCT CODE: 2188738
The global AI in breast imaging market size was valued at USD 305.9 million in 2025 and is projected to grow from USD 391.9 million in 2026 to USD 1,824.8 million by 2033, at a CAGR of 24.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.1% in 2025. The industry is driven by the increasing adoption of AI-assisted breast cancer screening and diagnosis, along with rising breast cancer incidence and screening volumes. Growing demand for radiologist workflow support and the expanding use of AI for cancer detection, breast density assessment, risk prediction, and diagnostic decision support are also driving the market.
AI-based solutions are being applied across mammography, digital breast tomosynthesis, breast ultrasound, and breast MRI for cancer detection and localization, lesion characterization, breast density assessment, risk prediction, image reconstruction, and workflow support. Recent clinical evidence is expanding the potential role of AI beyond basic detection. In July 2026, a study published in Radiology evaluated more than 577,000 screening mammograms across 109 U.S. imaging sites and found that integration of DeepHealth's AI-powered workflow increased the adjusted cancer detection rate among general radiologists by 32.7%, from 3.76 to 4.99 cancers per 1,000 examinations, reaching a level comparable to breast imaging specialists using the same workflow. AI applications are also expanding toward long-term risk assessment.
In September 2026, a study evaluated the IICM+ AI model for predicting distant breast cancer recurrence in patients with early-stage HR+/HER2-negative, node-negative disease. The model achieved a C-index of 0.735 compared with 0.578 for the 21-gene Recurrence Score in a separate validation group, although additional validation across larger and more diverse populations is required before routine clinical use. These developments are broadening the addressable application landscape toward cancer detection, diagnostic decision support, image-based risk prediction, and treatment monitoring. Regulatory clearances, clinical validation, digital imaging infrastructure, cloud-based deployment, and partnerships between AI developers and healthcare providers are further supporting market expansion.
Global AI in Breast Imaging Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends & opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented global AI in breast imaging market report based on imaging modality, application, clinical use, end use, deployment, and region: